Bio-Rad Laboratories Profit Margin 2006-2019 | BIO

Current and historical gross margin, operating margin and net profit margin for Bio-Rad Laboratories (BIO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bio-Rad Laboratories net profit margin as of September 30, 2019 is 16.14%.
Bio-Rad Laboratories Annual Profit Margins
Bio-Rad Laboratories Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $11.366B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.317B 22.01
Abbott Laboratories (ABT) United States $156.119B 28.48
Stryker (SYK) United States $78.360B 26.35
Boston Scientific (BSX) United States $60.213B 28.42
Baxter (BAX) United States $45.945B 27.86
EssilorLuxottica Societe Anonyme (ESLOY) France $34.669B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.600B 19.20
Lonza Group Ag (LZAGY) Switzerland $28.331B 0.00
Terumo (TRUMY) Japan $27.798B 34.69
Coloplast (CLPBY) Denmark $27.302B 42.13
ResMed (RMD) United States $23.111B 42.63
Smith & Nephew SNATS (SNN) United Kingdom $21.536B 0.00
Sunny Optical Technology (SNPTF) China $19.930B 0.00
Insulet (PODD) United States $11.836B 563.12
Canopy Growth (CGC) Canada $8.470B 0.00
Perrigo (PRGO) Ireland $8.100B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.790B 22.90
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.880B 39.73
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.131B 32.53
ICU Medical (ICUI) United States $3.896B 25.40
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.677B 61.18
Quidel (QDEL) United States $3.119B 29.60
Agios Pharmaceuticals (AGIO) United States $3.035B 0.00
National Vision Holdings (EYE) United States $2.590B 58.45
Aurora Cannabis (ACB) Canada $2.342B 0.00
Cardiovascular Systems (CSII) United States $1.844B 0.00
AtriCure (ATRC) United States $1.453B 0.00
InMode (INMD) Israel $1.430B 0.00
TG Therapeutics (TGTX) United States $1.397B 0.00
Aphria (APHA) $1.311B 0.00
VAREX IMAGING (VREX) United States $1.218B 24.35
NanoString Technologies (NSTG) United States $1.102B 0.00
Phibro Animal Health (PAHC) United States $1.058B 19.82
PetIQ (PETQ) United States $0.884B 21.56
Eagle Pharmaceuticals (EGRX) United States $0.814B 31.18
Lantheus Holdings (LNTH) United States $0.740B 18.49
LeMaitre Vascular (LMAT) United States $0.740B 41.57
Omeros (OMER) United States $0.736B 0.00
Quanterix (QTRX) United States $0.693B 0.00
Cerus (CERS) United States $0.589B 0.00
MacroGenics (MGNX) United States $0.567B 0.00
Surmodics (SRDX) United States $0.561B 58.15
Organigram Holdings (OGI) Canada $0.531B 0.00
OraSure Technologies (OSUR) United States $0.515B 30.93
HEXO (HEXO) $0.484B 0.00
Meridian Bioscience (VIVO) United States $0.428B 14.71
Utah Medical Products (UTMD) United States $0.392B 28.40
Owens & Minor (OMI) United States $0.364B 13.47
Zynex (ZYXI) United States $0.346B 39.19
BioLife Solutions (BLFS) United States $0.325B 132.50
Bovie Medical (APYX) United States $0.286B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.272B 0.00
Female Health (VERU) United States $0.267B 0.00
Vapotherm (VAPO) United States $0.252B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Viemed Healthcare (VMD) United States $0.216B 22.80
Repro-Med Systems (KRMD) United States $0.215B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.188B 0.00
Rockwell Medical (RMTI) United States $0.182B 0.00
Liberty Health Sciences (LHSIF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.171B 861.00
Cytosorbents (CTSO) United States $0.151B 0.00
Fonar (FONR) United States $0.136B 9.59
Chimerix (CMRX) United States $0.127B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 22.83
MRI Interventions (MRIC) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.087B 0.00
Nephros (NEPH) United States $0.079B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) $0.046B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00